Compare VCRE & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCRE | MTRX |
|---|---|---|
| Founded | 2000 | 1984 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | | Engineering & Construction |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 264.8M |
| IPO Year | 2026 | 1995 |
| Metric | VCRE | MTRX |
|---|---|---|
| Price | $11.14 | $9.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $24.94 | $15.00 |
| AVG Volume (30 Days) | 18.7K | ★ 478.8K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.51 |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $873,632,000.00 |
| Revenue This Year | $232.72 | $6.70 |
| Revenue Next Year | $340.16 | $5.71 |
| P/E Ratio | ★ N/A | $42.09 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $7.88 | $8.47 |
| 52 Week High | $14.01 | $14.64 |
| Indicator | VCRE | MTRX |
|---|---|---|
| Relative Strength Index (RSI) | 62.41 | 42.79 |
| Support Level | $10.56 | N/A |
| Resistance Level | $11.88 | $10.11 |
| Average True Range (ATR) | 0.43 | 0.50 |
| MACD | 0.25 | -0.02 |
| Stochastic Oscillator | 98.31 | 47.11 |
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
Matrix Service Co provides engineering, fabrication, construction, and maintenance services supporting critical energy infrastructure and industrial markets. Its reportable segments are Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities, with Storage and Terminal Solutions generating the maximum revenue. This segment provides integrated EPC, repair, maintenance, and fabrication services for bulk liquid, cryogenic, and refrigerated storage and terminal facilities supporting traditional and emerging energy markets, including LNG, NGLs, petroleum products, chemicals, hydrogen, and ammonia, and manufactures specialty tank products. The majority of revenue is generated from the United States.